AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Twist Bioscience Corporat... (TWST)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

46.70

-0.89 (-1.87%)

At close: Feb 18, 2025, 3:59 PM

46.70

0.00%

After-hours: Feb 18, 2025, 04:00 PM EST

undefined% (undefined)

Bid	44.93
Market Cap	2.79B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-3.38
PE Ratio (ttm)	-13.82
Forward PE	n/a
Analyst	Buy

Ask	48.47
Volume	809,945
Avg. Volume (20D)	826,089
Open	49.40
Previous Close	47.59
Day's Range	46.25 - 51.00
52-Week Range	27.41 - 60.90
Beta	undefined

About TWST

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration ...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Oct 31, 2018

Employees 923

Stock Exchange NASDAQ

Ticker Symbol TWST

Website https://www.twistbioscience.com

Full Company Profile

Analyst Forecast

According to 9 analyst ratings, the average rating for TWST stock is "Buy." The 12-month stock price forecast is $55.5, which is an increase of 18.84% from the latest price.

Buy 88.89%

Hold 0.00%

Sell 11.11%

Stock Forecasts

Next Earnings Release

Twist Bioscience Corporation is scheduled to release its earnings on May 1, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+9.87%

Twist Bioscience shares are trading higher after L... Unlock content with Pro Subscription

3 months ago

+12.31%

Twist Bioscience shares are trading higher after the company reported better-than-expected Q4 EPS and sales.

News

1 week ago · zacks.com

Twist Bioscience (TWST) Upgraded to Buy: Here's What You Should Know

Twist Bioscience (TWST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 week ago · finbold.com

Cathie Wood dumped Palantir to buy these biotech stocks

Ark Invest Management chief executive officer (CEO) Cathie Wood is a lauded yet controversial figure.

2 weeks ago · seekingalpha.com

Twist Bioscience: Valuation Is Weighing On The Stock

Twist Bioscience reported solid Q1 FY25 results, although this was insufficient to drive the company's share price higher. The demand environment remains challenging, and Trump's election has created ...

2 weeks ago · seekingalpha.com

Twist Bioscience Corporation (TWST) Q1 2025 Earnings Call Transcript

Twist Bioscience Corporation (NASDAQ:TWST ) Q1 2025 Earnings Conference Call February 3, 2025 8:00 AM ET Company Participants Angela Bitting - Senior Vice President of Corporate Affairs Emily Leproust...

2 weeks ago · zacks.com

Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $0.75 per share a year ago.

2 weeks ago · businesswire.com

Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...

1 month ago · zacks.com

All You Need to Know About Twist Bioscience (TWST) Rating Upgrade to Buy

Twist Bioscience (TWST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago · zacks.com

Twist Bioscience (TWST) Surges 9.9%: Is This an Indication of Further Gains?

Twist Bioscience (TWST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near ...

2 months ago · businesswire.com

Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announce...

2 months ago · zacks.com

Twist Bioscience (TWST) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Twist Bioscience (TWST), indicating that the stock has found support. This, combined with an upward trend in earnings estimat...

Load More News